We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Grid Computing Enables Large-Scale Pharmaceutical Patent Searches

By LabMedica International staff writers
Posted on 28 Jan 2010
Two German institutes are utilizing automated annotation software on grid-connected supercomputers to perform powerful queries in more than 50,000 pharmaceutical patents.

Researchers from the Fraunhofer Institute for Algorithms and Scientific Computing (SCAI; Saint Augustin, Germany) and the Jülich Supercomputing Center of Forschungszentrum Jülich (JSC; Germany) have used their considerable grid computing infrastructures for a new application in scientific computing: the large-scale annotation of biomedical and chemical texts and images in pharmaceutical patents. More...
This will allow patent searches of an unparalleled power. Now, queries provide interesting insights into intersections between biology and chemistry, and the analysis of chemistry is truly multimodal in the sense that text- and image-based information can be analyzed simultaneously.

More than 50,000 patents describing inventions in pharmaceutical chemistry have been processed on the large-scale computing grid infrastructures at SCAI and JSC. Automated "named entity recognition” services have identified and annotated: biologic entities in text (e.g., protein names; gene names; gene polymorphisms; cell types); medical entities in text (e.g., disease names; pathology terms; risk factor terminology); as well as chemical information in text (e.g., drug names; expressions following the naming standards of the International Union of Pure and Applied Chemistry [IUPAC]); and images (e.g., chemical structure depictions).

The grid middleware UNICORE (Uniform Interface to Computing Resources) was used to manage the annotation services in the grid infrastructure, to control the streams of input and output data from the patents database to the annotation services, and to monitor the overall progress.

"This large-scale experiment opens new perspectives in scientific computing,” commented Prof. Dr. Martin Hofmann-Apitius, head of the department of bioinformatics at Fraunhofer SCAI. "This type of application goes way beyond the usual simulation applications that we are used to in the scientific computing community.”

Up to now, text-mining applications have only been run on bibliographic databases of life sciences and biomedical information such as MEDLINE. But the extension towards a multimodal analysis including annotation of text- and image-based information in full text documents on grid infrastructures has never been done before.

"We are pleased to see that our institute, which has a strong record in numerical simulation, has contributed to a new field of applications for supercomputers: what we call knowledge computing is likely to become a new discipline on its own,” emphasized Prof. Dr. Ulrich Trottenberg, director of Fraunhofer SCAI.

"UNICORE made it possible to run this experiment at such a large scale in computing grid infrastructures at SCAI and JSC,” stated Dr. Achim Streit, head of Distributed Systems and Grid Computing at JSC. "The powerful workflow and data management capabilities of UNICORE allowed to annotate the patents in a seamless and automated way. A supercomputer connected by UNICORE to the infrastructure of the German Grid Initiative [D-Grid] was used to perform the knowledge extraction. This initial step of the experiment demonstrates what is possible today and shows the potential for more complex production runs in the future, using HPC systems connected in grid infrastructures.”

"This is a very good example of how powerful supercomputers at JSC equipped with world-class grid technologies like UNICORE can generate synergies to enable new fields of research. I am proud that JSC is a member of the international UNICORE open source community and leads its development,” explained Prof. Dr. Dr. Thomas Lippert, director of JSC.

The team at SCAI, led by Dr. Marc Zimmermann for the image analysis annotators and by Dr. Juliane Fluck and Dr. Christoph Friedrich for the text analytics part, is currently working on the in-depth analysis of the metainformation generated in the course of this large-scale in silico-experiment.

Related Links:

Fraunhofer Institute for Algorithms and Scientific Computing
Jülich Supercomputing Centre




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.